fx Life Sciences AG
Patent Applications and Registrations
Patent applications and USPTO patent grants for fx Life Sciences AG.The latest application filed is for "uses of north american ginseng fractions for treating leukemia".
- fx Life Sciences AG - Zug CH
- fx Life Sciences AG -
Trademarks
| Patent | Date |
|---|---|
| Uses Of North American Ginseng Fractions For Treating Leukemia App 20130243891 - Shan; Jacqueline ; et al. | 2013-09-19 |
| Treatment of autoimmune diseases with American ginseng extract Grant 8,039,027 - Guilbert , et al. October 18, 2 | 2011-10-18 |
| Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium Grant 7,906,150 - Pang , et al. March 15, 2 | 2011-03-15 |
| Processes Of Making North American Ginseng Fractions, Products Containing Them, And Use As Immunomodulators App 20100278945 - Shan; Jacqueline J. ; et al. | 2010-11-04 |
| Uses Of North American Ginseng Fractions For Treating Leukemia App 20100260871 - Shan; Jacqueline ; et al. | 2010-10-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 